{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:39:00Z","timestamp":1792535940201,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01285-6","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:54:57Z","timestamp":1792486497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcome measures and monitoring framework in juvenile systemic sclerosis: bridging routine care and clinical trials"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0659-5298","authenticated-orcid":false,"given":"Ivan","family":"Foeldvari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-3268","authenticated-orcid":false,"given":"Edoardo","family":"Marrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"2","key":"1285_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/2397198318763701","volume":"3","author":"T Beukelman","year":"2018","unstructured":"Beukelman T, Xie F, Foeldvari I. Assessing the prevalence of juvenile systemic sclerosis in childhood using administrative claims data from the United States. J Scleroderma Relat Disorders. 2018;3(2):189\u201390.","journal-title":"J Scleroderma Relat Disorders"},{"issue":"4","key":"1285_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/1744666X.2023.2298354","volume":"20","author":"I Foeldvari","year":"2024","unstructured":"Foeldvari I, Torok KS, Anton J, Blakley M, Constantin T, Cutolo M, et al. Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022. Expert Rev Clin Immunol. 2024;20(4):387\u2013404.","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"1285_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/1744666X.2025.2474216","volume":"21","author":"I Foeldvari","year":"2025","unstructured":"Foeldvari I, Torok KS, Silva J, Denton CP, Henes J, Horvei P, et al. Guidance for stem cell therapy for juvenile systemic sclerosis patients. Expert Rev Clin Immunol. 2025;21(4):435\u201350.","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"1285_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/23971983221143244","volume":"8","author":"I Foeldvari","year":"2023","unstructured":"Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri MT, Sakamoto AP, et al. Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort. J Scleroderma Relat Disord. 2023;8(2):120\u201330.","journal-title":"J Scleroderma Relat Disord"},{"issue":"8","key":"1285_CR5","first-page":"1627","volume":"44","author":"N Vasquez-Canizares","year":"2026","unstructured":"Vasquez-Canizares N, Twilt M, McCormick Q, Bhave P, Dobre IA, Li SC. Juvenile- and adult-onset systemic sclerosis: similarities and differences in early disease patterns: a scoping review. Clin Exp Rheumatol. 2026;44(8):1627\u201334.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1285_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/acr.24499","volume":"74","author":"I Foeldvari","year":"2022","unstructured":"Foeldvari I, Klotsche J, Hinrichs B, Helmus N, Kasapcopur O, Adrovic A, et al. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis. Arthritis Care Res (Hoboken). 2022;74(3):364\u201370.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1285_CR7","doi-asserted-by":"crossref","unstructured":"Tugwell P, Boers M, D\u2019Agostino MA, Beaton D, Boonen A, Bingham CO 3, et al. Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of truth: content, face, and construct validity. J Rheumatol. 2014;41(5):1000\u20134.","DOI":"10.3899\/jrheum.131310"},{"issue":"4","key":"1285_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/rheumatology\/keaa584","volume":"60","author":"I Foeldvari","year":"2021","unstructured":"Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, et al. Consensus-based recommendations for the management of juvenile systemic sclerosis. Rheumatology (Oxford). 2021;60(4):1651\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1285_CR9","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1093\/rheumatology\/keae394","volume":"63","author":"CP Denton","year":"2024","unstructured":"Denton CP, De Lorenzis E, Roblin E, Goldman N, Alcacer-Pitarch B, Blamont E, et al. The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology (Oxford). 2024;63(11):2956\u201375.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1285_CR10","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1093\/rheumatology\/keaf249","volume":"64","author":"CE Pain","year":"2025","unstructured":"Pain CE, Lythgoe H, Willis E, Sampath S, Deepak S, Torok KS, et al. Evaluating the relevance of the 2024 BSR systemic sclerosis guideline for juvenile systemic sclerosis. Rheumatology (Oxford). 2025;64(9):5179\u201381.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1285_CR11","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1002\/art.34652","volume":"64","author":"F La Torre","year":"2012","unstructured":"La Torre F, Martini G, Russo R, Katsicas MM, Corona F, Calcagno G, et al. A preliminary disease severity score for juvenile systemic sclerosis. Arthritis Rheum. 2012;64(12):4143\u201350.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1285_CR12","first-page":"2159","volume":"26","author":"TA Medsger Jr","year":"1999","unstructured":"Medsger TA Jr., Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26(10):2159\u201367.","journal-title":"J Rheumatol"},{"issue":"11","key":"1285_CR13","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/art.42939","volume":"76","author":"L Ross","year":"2024","unstructured":"Ross L, Hansen D, Proudman S, Khanna D, Herrick AL, Stevens W, et al. Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index. Arthritis Rheumatol. 2024;76(11):1635\u201344.","journal-title":"Arthritis Rheumatol"},{"key":"1285_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/annrheumdis-2020-219100","volume":"80","author":"D Khanna","year":"2021","unstructured":"Khanna D, Huang S, Lin CJF, Spino C. New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis. Ann Rheum Dis. 2021;80:641\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 100","key":"1285_CR15","first-page":"148","volume":"34","author":"K Melsens","year":"2016","unstructured":"Melsens K, De Keyser F, Decuman S, Brusselle G, De Pauw M, Deschepper E, et al. Assessment of sensitivity to change of the European Scleroderma Study Group activity index. Clin Exp Rheumatol. 2016;34(Suppl 100):148\u201351.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"1285_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/rheumatology\/keq022","volume":"49","author":"T Minier","year":"2010","unstructured":"Minier T, Nagy Z, Balint Z, Farkas H, Radics J, Kumanovics G, et al. Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis. Rheumatology (Oxford). 2010;49(6):1133\u201345.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1285_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, et al. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis. 2017;76(1):270\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1285_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/23971983231164700","volume":"8","author":"J Klotsche","year":"2023","unstructured":"Klotsche J, Torok KS, Kasapcopur O, Adrovic A, Terreri MT, Sakamoto AP, et al. Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis. J Scleroderma Relat Disord. 2023;8(3):183\u201391.","journal-title":"J Scleroderma Relat Disord"},{"key":"1285_CR19","doi-asserted-by":"crossref","unstructured":"Foeldvari I, Torok KS, Klotsche J, Li JC, Bruni C, Costa-Reis P, et al. Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium. Expert Rev Clin Immunol. 2026.","DOI":"10.1080\/1744666X.2026.2685050"},{"issue":"10","key":"1285_CR20","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/acr.24609","volume":"74","author":"I Foeldvari","year":"2022","unstructured":"Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri MT, Sakamoto AP, et al. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort. Arthritis Care Res (Hoboken). 2022;74(10):1575\u201384.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"1285_CR21","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/acr.25171","volume":"75","author":"I Foeldvari","year":"2023","unstructured":"Foeldvari I, Torok KS, Anton J, Blakley M, Constantin T, Curran M, et al. Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings. Arthritis Care Res (Hoboken). 2023;75(12):2453\u201362.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1285_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2(1):11\u20138.","journal-title":"J Scleroderma Relat Disord"},{"key":"1285_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/rheumatology\/kei106","volume":"45","author":"I Foeldvari","year":"2006","unstructured":"Foeldvari I, Wierk A. Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score. Rheumatology. 2006;45:76\u20138.","journal-title":"Rheumatology"},{"issue":"3","key":"1285_CR24","doi-asserted-by":"publisher","first-page":"101688","DOI":"10.1016\/j.berh.2021.101688","volume":"35","author":"I Foeldvari","year":"2021","unstructured":"Foeldvari I, Torok KS. Review for best practice in clinical rheumatology juvenile systemic sclerosis - Updates and practice points. Best Pract Res Clin Rheumatol. 2021;35(3):101688.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"1285_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/annrheumdis-2016-210534","volume":"76","author":"A Man","year":"2017","unstructured":"Man A, Correa JK, Ziemek J, Simms RW, Felson DT, Lafyatis R. Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis. Ann Rheum Dis. 2017;76(8):1374\u201380.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1285_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/jdv.20321","volume":"39","author":"J Vyas","year":"2025","unstructured":"Vyas J, Johns JR, Abdelrazik Y, Ali FM, Ingram JR, Salek S, et al. The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review. J Eur Acad Dermatol Venereol. 2025;39(3):631\u201379.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1285_CR27","doi-asserted-by":"publisher","first-page":"e0245434","DOI":"10.1371\/journal.pone.0245434","volume":"16","author":"PM Wardyn","year":"2021","unstructured":"Wardyn PM, de Broucker V, Chenivesse C, Sobaszek A, Van Bulck R, Perez T, et al. Assessing the applicability of the new Global Lung Function Initiative reference values for the diffusing capacity of the lung for carbon monoxide in a large population set. PLoS ONE. 2021;16(1):e0245434.","journal-title":"PLoS ONE"},{"issue":"11","key":"1285_CR28","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/acr.25567","volume":"77","author":"RM Fairchild","year":"2025","unstructured":"Fairchild RM, Mar DA, Deluna MD, Chung M, Davuluri S, Kawano Y, et al. Validation of Lung Ultrasound Interpretation Criteria for Interstitial Lung Disease in Systemic Sclerosis and Inflammatory Myopathy. Arthritis Care Res (Hoboken). 2025;77(11):1384\u201392.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"1285_CR29","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/rheumatology\/kez571","volume":"59","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chen S, Lin J, Xie X, Hu S, Lin Q, et al. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease. Rheumatology (Oxford). 2020;59(8):2024\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1285_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/acr.25485","volume":"77","author":"ER Volkmann","year":"2025","unstructured":"Volkmann ER, Wilhalme H, Tashkin DP, Kim GHJ, Goldin J, Haussmann A, et al. Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis Care Res (Hoboken). 2025;77(6):753\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"1285_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/adc.2007.123653","volume":"93","author":"AE Lammers","year":"2008","unstructured":"Lammers AE, Hislop AA, Flynn Y, Haworth SG. The 6-minute walk test: normal values for children of 4\u201311 years of age. Arch Dis Child. 2008;93(6):464\u20138.","journal-title":"Arch Dis Child"},{"issue":"Suppl 11","key":"1285_CR32","first-page":"S98","volume":"63","author":"J Pope","year":"2011","unstructured":"Pope J. Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler\u2019s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud\u2019s Condition Score (RCS). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S98\u2013111.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1285_CR33","doi-asserted-by":"crossref","unstructured":"Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, et al. Nintedanib in children and adolescents with fibrosing interstitial lung diseases. Eur Respir J. 2023;61(2).","DOI":"10.1183\/13993003.01512-2022"},{"issue":"SI","key":"1285_CR34","doi-asserted-by":"publisher","first-page":"SI21","DOI":"10.1093\/rheumatology\/keae571","volume":"64","author":"CJW Stock","year":"2025","unstructured":"Stock CJW, Nan Y, Fang Y, Kokosi M, Kouranos V, George PM, et al. Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival. Rheumatology (Oxford). 2025;64(SI):SI21\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"1285_CR35","doi-asserted-by":"crossref","unstructured":"Soo CY, Jex N, Bissell LA, Del Galdo F, Plein S. Cardiac involvement in systemic sclerosis: mechanisms, manifestations and management. Rheumatology (Oxford). 2026;65(5).","DOI":"10.1093\/rheumatology\/keag064"},{"issue":"1","key":"1285_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.semarthrit.2019.06.013","volume":"50","author":"V Poindron","year":"2020","unstructured":"Poindron V, Chatelus E, Canuet M, Gottenberg JE, Arnaud L, Gangi A, et al. T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients. Semin Arthritis Rheum. 2020;50(1):128\u201334.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1285_CR37","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/rheumatology\/keac504","volume":"62","author":"S Panopoulos","year":"2023","unstructured":"Panopoulos S, Mavrogeni S, Vlachopoulos C, Sfikakis PP. Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis. Rheumatology (Oxford). 2023;62(4):1535\u201342.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1285_CR38","doi-asserted-by":"publisher","first-page":"e15825","DOI":"10.1111\/ped.15825","volume":"66","author":"H Oka","year":"2024","unstructured":"Oka H, Sato M, Ito K, Ishibazawa E, Nagamori T, Nakau K, et al. The usefulness of parametric mapping in a patient with juvenile systemic sclerosis. Pediatr Int. 2024;66(1):e15825.","journal-title":"Pediatr Int"},{"key":"1285_CR39","doi-asserted-by":"crossref","unstructured":"Fairley JL, Hansen D, Proudman S, Sahhar J, Ngian GS, Apostolopoulos D, et al. Frequency and determinants of use of immunosuppressants in the Australian scleroderma cohort study. J Scleroderma Relat Disord. 2025:23971983251342690.","DOI":"10.1177\/23971983251342690"},{"issue":"1","key":"1285_CR40","doi-asserted-by":"publisher","first-page":"102891","DOI":"10.1016\/j.cpcardiol.2024.102891","volume":"50","author":"D Bacich","year":"2025","unstructured":"Bacich D, Tessari C, Andreis M, Geatti V, Cattapan I, Pradegan N, et al. Heart transplantation in juvenile-onset systemic sclerosis with primary cardiac involvement: report of two cases and comprehensive literature review. Curr Probl Cardiol. 2025;50(1):102891.","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"1285_CR41","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1016\/j.acra.2024.12.035","volume":"32","author":"H Chalian","year":"2025","unstructured":"Chalian H, Askarinejad A, Salmanipour A, Jolfayi AG, Bedayat A, Ordovas K, et al. The Role of Cardiac Magnetic Resonance Imaging Parameters in Prognostication of Systemic Sclerosis in Patients with Cardiac Involvement: A Systematic Review of the Literature. Acad Radiol. 2025;32(6):3248\u201357.","journal-title":"Acad Radiol"},{"issue":"3","key":"1285_CR42","doi-asserted-by":"publisher","first-page":"101668","DOI":"10.1016\/j.berh.2021.101668","volume":"35","author":"C Bruni","year":"2021","unstructured":"Bruni C, Ross L. Cardiac involvement in systemic sclerosis: Getting to the heart of the matter. Best Pract Res Clin Rheumatol. 2021;35(3):101668.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1285_CR43","doi-asserted-by":"crossref","unstructured":"Rosenzweig EB, Abman SH, Adatia I, Beghetti M, Bonnet D, Haworth S, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J. 2019;53(1).","DOI":"10.1183\/13993003.01916-2018"},{"issue":"7","key":"1285_CR44","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Grunig E, Bonderman D, Distler O, Khanna D, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73(7):1340\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1285_CR45","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12016-022-08945-x","volume":"64","author":"A Cole","year":"2023","unstructured":"Cole A, Ong VH, Denton CP. Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis. Clin Rev Allergy Immunol. 2023;64(3):378\u201391.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"1285_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/acr.25643","volume":"78","author":"S Stefancic","year":"2026","unstructured":"Stefancic S, Robinson A, Havrilla HJ, Sood V, Torok KS. Gastrointestinal Impact and Tool Performance in Juvenile Systemic Sclerosis Using the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract, Version 2.0 Assessment. Arthritis Care Res (Hoboken). 2026;78(4):449\u201355.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"1285_CR47","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.crad.2021.04.014","volume":"76","author":"FT Delaney","year":"2021","unstructured":"Delaney FT, Fenlon HM, Buckley B, Welaratne I, Cronin CG. Multimodality imaging of the gastrointestinal manifestations of scleroderma. Clin Radiol. 2021;76(9):640\u20139.","journal-title":"Clin Radiol"},{"issue":"8","key":"1285_CR48","first-page":"1662","volume":"44","author":"LA Robinson","year":"2026","unstructured":"Robinson LA, Willis E, Kasapcopur O, Gunalp A, Vasquez-Canizares N, Twilt M, et al. Outcome measures used to assess gastrointestinal tract involvement in adults and children with systemic sclerosis: a scoping review. Clin Exp Rheumatol. 2026;44(8):1662\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"1285_CR49","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/art.24730","volume":"61","author":"D Khanna","year":"2009","unstructured":"Khanna D, Hays RD, Maranian P, Seibold JR, Impens A, Mayes MD, et al. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum. 2009;61(9):1257\u201363.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1285_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3899\/jrheum.171486","volume":"46","author":"C Bruni","year":"2019","unstructured":"Bruni C, Ngcozana T, Braschi F, Pucci T, Piemonte G, Benelli L, et al. Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. J Rheumatol. 2019;46(6):603\u20138.","journal-title":"J Rheumatol"},{"issue":"8","key":"1285_CR51","first-page":"1645","volume":"44","author":"V Maniscalco","year":"2026","unstructured":"Maniscalco V, Vasquez-Canizares N, Lemon J, Stead L, Leone V, Clarke K, et al. Domains and outcome measures for the assessment of digital vasculopathy and Raynaud\u2019s phenomenon in adult and juvenile systemic sclerosis: a scoping literature review. Clin Exp Rheumatol. 2026;44(8):1645\u201352.","journal-title":"Clin Exp Rheumatol"},{"key":"1285_CR52","doi-asserted-by":"publisher","first-page":"152845","DOI":"10.1016\/j.semarthrit.2025.152845","volume":"75","author":"C Valera-Ribera","year":"2025","unstructured":"Valera-Ribera C, Alegre-Sancho JJ, Lacasa-Molina J, Robustillo-Villarino M, Narvaez J. Nailfold capillaroscopy as a predictor of major cardiovascular events and mortality in systemic sclerosis. Semin Arthritis Rheum. 2025;75:152845.","journal-title":"Semin Arthritis Rheum"},{"key":"1285_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2017.02.001","volume":"112","author":"G Dinsdale","year":"2017","unstructured":"Dinsdale G, Moore T, O\u2019Leary N, Tresadern P, Berks M, Roberts C, et al. Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy. Microvasc Res. 2017;112:1\u20136.","journal-title":"Microvasc Res"},{"issue":"1","key":"1285_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ero.2026.02.006","volume":"2","author":"DA Haverkort","year":"2026","unstructured":"Haverkort DA, den Broeder AA, Kersten BE, Smith V, Vonk MC. Early progression of systemic sclerosis: a longitudinal cohort study on disease evolution and microvascular changes. EULAR Rheumatol Open. 2026;2(1):326\u201331.","journal-title":"EULAR Rheumatol Open"},{"key":"1285_CR55","doi-asserted-by":"crossref","unstructured":"Velauthapillai A, de Vries-Bouwstra JK, Henes J, Czirjak L, Dagna L, Riemekastan G, et al. Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: a EUSTAR database analysis. J Scleroderma Relat Disord. 2025:23971983241307692.","DOI":"10.1177\/23971983241307692"},{"issue":"4","key":"1285_CR56","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/rheumatology\/keac487","volume":"62","author":"K Melsens","year":"2023","unstructured":"Melsens K, Cutolo M, Schonenberg-Meinema D, Foeldvari I, Leone MC, Mostmans Y, et al. Standardised nailfold capillaroscopy in children with rheumatic diseases: a worldwide study. Rheumatology (Oxford). 2023;62(4):1605\u201315.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1285_CR57","doi-asserted-by":"publisher","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","volume":"18","author":"V Smith","year":"2019","unstructured":"Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, et al. Fast track algorithm: How to differentiate a scleroderma pattern from a non-scleroderma pattern. Autoimmun Rev. 2019;18(11):102394.","journal-title":"Autoimmun Rev"},{"key":"1285_CR58","doi-asserted-by":"crossref","unstructured":"Foeldvari I, Klotsche J, Torok K, Kasapcopur O, Adrovic A, et al. Presence of nailfold capillary changes correlates with more severe organ involvement in juvenile systemic scleroderma. Results of the Juvenile Scleroderma Inception Cohort. Annals oi Rheumatic Disease. 2024;83(Supplement 1).","DOI":"10.1136\/annrheumdis-2024-eular.2145"},{"key":"1285_CR59","doi-asserted-by":"crossref","unstructured":"Eden M, Wilkinson S, Murray A, Gurunath Bharathi P, Vail A, Taylor C, et al. Nailfold capillaroscopy: a survey of current UK practice and \u2018next steps\u2019 to increase uptake amongst rheumatologists. Rheumatology (Oxford). 2022.","DOI":"10.1093\/rheumatology\/keac133.116"},{"key":"1285_CR60","doi-asserted-by":"crossref","unstructured":"Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis. Autoimmun Rev. 2020:102458.","DOI":"10.1016\/j.autrev.2020.102458"},{"issue":"8","key":"1285_CR61","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.autrev.2018.01.023","volume":"17","author":"M Cutolo","year":"2018","unstructured":"Cutolo M, Vanhaecke A, Ruaro B, Deschepper E, Ickinger C, Melsens K, et al. Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients. Autoimmun Rev. 2018;17(8):775\u201380.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"1285_CR62","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/acr.23729","volume":"71","author":"JD Pauling","year":"2019","unstructured":"Pauling JD, Reilly E, Smith T, Frech TM. Evolving Symptom Characteristics of Raynaud\u2019s Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity. Arthritis Care Res (Hoboken). 2019;71(8):1119\u201326.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"1285_CR63","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2010;62(4):465\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1285_CR64","doi-asserted-by":"crossref","unstructured":"Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S118\u201357.","DOI":"10.1002\/acr.20532"},{"issue":"8","key":"1285_CR65","first-page":"1635","volume":"44","author":"V Maniscalco","year":"2026","unstructured":"Maniscalco V, Cakan M, Robinson A, Vasquez-Canizares N, Lu M, Zheng R, et al. Outcome measures for cutaneous and musculoskeletal involvement in juvenile systemic sclerosis: a scoping literature review. Clin Exp Rheumatol. 2026;44(8):1635\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"1285_CR66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/14397595.2020.1816612","volume":"31","author":"A Dag","year":"2021","unstructured":"Dag A, Tarakci E, Adrovic A, Kasapcopur O. Effects of sense and functionality changes in the hands on activity and participation in patients with juvenile scleroderma. Mod Rheumatol. 2021;31(3):657\u201368.","journal-title":"Mod Rheumatol"},{"key":"1285_CR67","doi-asserted-by":"crossref","unstructured":"Dobrota R, Garaiman A, Fligelstone K, Tyrrell Kennedy A, Roennow A, Allanore Y, et al. Performance of the EULAR systemic sclerosis impact of disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis. RMD Open. 2024;10(4).","DOI":"10.1136\/rmdopen-2024-004653"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01285-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01285-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01285-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:02:05Z","timestamp":1792533725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01285-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01285-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"77"}}